Assisted Exercise in Prematurity; Effects and Mechanisms

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2011 by University of California, Irvine.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of California, Irvine
ClinicalTrials.gov Identifier:
NCT00580099
First received: December 18, 2007
Last updated: April 8, 2011
Last verified: April 2011

December 18, 2007
April 8, 2011
September 2005
March 2011   (final data collection date for primary outcome measure)
Body composition, bone mineralization, muscle mass, anthropometric measurements [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
Body composition, bone mineralization, muscle mass [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00580099 on ClinicalTrials.gov Archive Site
  • spontaneous movement [ Time Frame: two time points ] [ Designated as safety issue: No ]
  • Neurological/behavioral status [ Time Frame: end of 4th week ] [ Designated as safety issue: No ]
  • Blood Sampling to measure IGF-1, GHBP, IL-1ra [ Time Frame: Baseline, week 2 and week 4 ] [ Designated as safety issue: No ]
  • spontaneous movement [ Time Frame: two time points ] [ Designated as safety issue: No ]
  • Neurological/behavioral status [ Time Frame: end of 4th week ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Assisted Exercise in Prematurity; Effects and Mechanisms
Assisted Exercise in Prematurity; Effects and Mechanisms

Briefly our study is looking at the effects of 4 weeks of assisted exercise on the body composition and neurological/behavioral development of healthy growing premature infants enrolled between the ages of 30-33 weeks. It is a blinded study where the active group gets the exercise intervention and the control group is cuddled for the same amount of time -approximately 20 minutes. We get baseline data using muscle ultrasound, bone speed of sound and DEXA. We also get baseline blood samples to look at inflammatory mediators and growth hormone. Video of each subject is recorded an hour at two time points during the study to assess the babies for spontaneous activity. Nutritional intake information is collected daily and in the 4th week of the study assessments made for total energy expenditure using doubly labeled water. At this point in the study we repeat the ultrasounds and DEXA for comparison. Finally in the period just before discharge we do a complex neurological exam using the Brazelton NBAS assessment.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
  • Growth
  • Development
  • Other: assisted exercise
    4 weeks of passive range of motion exercise
  • Other: cuddle
    cuddle infant for 20 minutes
  • Experimental: 1
    4 weeks of assisted exercise using passive range of motion on all major joints
    Intervention: Other: assisted exercise
  • Active Comparator: 2
    cuddle for 20 minutes
    Intervention: Other: cuddle

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100
March 2012
March 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Preterm infants born at post menstrual ages of 23-33 weeks gestation Enrollment occurs at post menstrual age of 30 to 35 weeks.if their projected stay based on standard clinical criteria is four weeks after enrollment
  • Enrollment occurs at post menstrual age of 30 up to 35 weeks, if their projected stay based on standard clinical criteria is 4 weeks after enrollment.
  • Birth weight appropriate for gestational age (AGA) using current CDC growth charts. AGA is defined as plus or minus 2 standard deviations above the mean or above the third percentile.
  • Tolerating full enteral feeds at greater than or equal to 100kcal/kg/day

Exclusion Criteria:

  • Evidence of chromosomal or other major genetic abnormalities
  • Existence of current diseases or syndromes including:

central nervous system or other neurological abnormalities chronic lung disease of prematurity requiring chronic use of corticosteroids, musculoskeletal diseases

  • positive infant toxicology screen(urine) for drugs or alcohol
  • Both parents are under the age of 18 years
  • Babies with tracheostomy
  • Babies receiving ventilator assistance with breathing
  • Babies receiving IV fluids
Both
30 Weeks to 35 Weeks
No
Contact: Julia K Rich, RN 714-456-2946 jkrich@uci.edu
United States
 
NCT00580099
2005-4797, NIH Grant R01NR009070
Yes
Dan M. Cooper MD, University of California Irvine
University of California, Irvine
Not Provided
Principal Investigator: Dan M Cooper, MD University of California, Irvine
University of California, Irvine
April 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP